Bioventus (BVS)
(Real Time Quote from BATS)
$5.36 USD
+0.32 (6.35%)
Updated May 9, 2024 01:30 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (100 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.52 | 9.99 |
Current Quarter Estimate | 0.07 | -2.04 | 57.00 |
Year Ago Quarter Estimate | 0.14 | -0.59 | 52.54 |
Next Quarter Estimate | 0.06 | -2.00 | 61.00 |
Next Year Estimate | 0.40 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 700.00 | 12.00 | 15.67 |
Next Year | 150.00 | 14.90 | 9.31 |
Last 5 Years | NA | 5.50 | 8.10 |
Next 5 Years | NA | 22.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.27 | -5.88 |
Price/Book (MRQ) | 1.84 | 1.91 |
Price/Cash Flow (MRFY) | 6.37 | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -4.14% | 0.82% |
Return on Equity (TTM) | 11.91% | -24.69% |
Debt to Equity (MRQ) | 1.63 | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.